Weber H G
Fortschr Med. 1977 Jun 2;95(21):1381-6.
The world-wide smallpox eradication program sponsored by the WHO has been successful. Furthermore the legislation regarding smallpox vaccination in the Federal Republic of Germany has been given a new form. The place of the previous mass-vaccination has been taken by vaccination of individuals. Under this aspect safe procedures for vaccination are required. Any vaccination used by Public Health Service has to fulfill the following criteria: High protection against the disease without adverse side-effects or risks; it should be simple to administer and applicable under ordinary circumstances. For primary vaccination against smallpox the MVA-vaccination meets these demands entirely. It is reported about own experiences with 700 vaccinations using the attenuated virus "MVA"; complete documentation is given. Not a single complication nor any adverse side-effects have been seen. The Public Health Service has gained great experience in the field of vaccination. It is responsible for the protection of the individual as well as the public, as it is undesirable that there develops and unvaccinated group within the population. The individual claim a complete protection through vaccination which should be absolutely free of any risk.
由世界卫生组织发起的全球天花根除计划取得了成功。此外，德意志联邦共和国关于天花疫苗接种的立法也有了新形式。以前的大规模疫苗接种已被个体接种所取代。在这方面，需要安全的接种程序。公共卫生服务部门使用的任何疫苗都必须符合以下标准：对疾病有高度防护作用且无不良副作用或风险；易于接种且在普通情况下适用。对于天花的初次接种，改良痘苗病毒安卡拉（MVA）疫苗完全满足这些要求。报告了使用减毒病毒“MVA”进行700次接种的自身经验，并给出了完整记录。未观察到任何并发症或不良副作用。公共卫生服务部门在疫苗接种领域积累了丰富经验。它负责保护个体和公众，因为人群中出现未接种疫苗的群体是不可取的。个体要求通过绝对无任何风险的疫苗接种获得全面保护。
